About the Webinar
This webinar provides viewers with an update on shingles epidemiology and current trends in vaccination rates.
Low shingles vaccination rates in Australian adults impact the epidemiology of the disease. This webinar explores what current guidelines advise regarding improving shingles vaccination rates in Australia, and therefore reducing disease burden and complications.
It discusses the two shingles vaccinations available in Australia, comparing efficacy, safety, dosage regimens and indications for each vaccine.
- Describe the epidemiology of shingles in various population groups, including persons aged over 65 years
- Outline current vaccination rates in older Australians, and recognised strategies for improving uptake of shingles vaccines
- Explain the possible clinical sequelae associated with shingles, including serious complications, impact on quality of life, and the particular risk attributed to persons aged over 80 years.
- Identify the patients in whom shingles vaccination is a priority, based on age and medical comorbidities.
- Describe and compare the two shingles vaccines currently available in Australia, including safety profiles, efficacy, dosage regimens and costs.
Angela Newbound is an Immunisation Education Consultant based in South Australia, and is a member of the Immunisation Coalition. She has been involved in immunisation program delivery in South Australia for over 20 years, originally as an immunisation provider and in program coordinator roles within the Divisions of General Practice, SA Health Immunisation Section, the Medicare Local Network and presently the Primary Health Network. Angela provides clinical advice, support and education to a wide range of immunisation providers across South Australia and contributes to the development of immunisation resources to assist providers with challenging aspects of the immunisation program.
Click here to view or download a PDF of the slide presentation.